{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:39:29Z","timestamp":1792784369593,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2013CB911104"],"award-info":[{"award-number":["2013CB911104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2013CB911100"],"award-info":[{"award-number":["2013CB911100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 21572116"],"award-info":[{"award-number":["Grant No. 21572116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["20141081129"],"award-info":[{"award-number":["20141081129"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tianjin Science and Technology Program","award":["13JCYBJC24300"],"award-info":[{"award-number":["13JCYBJC24300"]}]},{"name":"Tianjin Science and Technology Program","award":["13JCQNJC13100"],"award-info":[{"award-number":["13JCQNJC13100"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.talanta.2016.05.036","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T02:45:00Z","timestamp":1463453100000},"page":"77-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Development, validation and clinical application of an online-SPE-LC-HRMS\/MS for simultaneous quantification of phenobarbital, phenytoin, carbamazepine, and its active metabolite carbamazepine 10,11-epoxide"],"prefix":"10.1016","volume":"158","author":[{"given":"Lihua","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2016.05.036_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/FTD.0b013e318167d11b","article-title":"Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs","volume":"30","author":"Anderson","year":"2008","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.talanta.2016.05.036_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4196\/kjpp.2011.15.2.67","article-title":"Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring, Korean","volume":"15","author":"Kang","year":"2011","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.talanta.2016.05.036_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1528-1157.2002.13001.x","article-title":"The importance of drug interactions in epilepsy therapy","volume":"43","author":"Patsalos","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.talanta.2016.05.036_bib4","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.talanta.2016.05.036_bib5","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.0013-9580.2004.12704.x","article-title":"Phenobarbital for the treatment of epilepsy in the 21st century: a critical review","volume":"45","author":"Kwan","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.talanta.2016.05.036_bib6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.seizure.2012.04.014","article-title":"Trends in antiepileptic drug utilisation in UK primary care 1993\u20132008: cohort study using the General Practice Research Database","volume":"21","author":"Nicholas","year":"2012","journal-title":"Seizure: Eur. J. Epilep."},{"key":"10.1016\/j.talanta.2016.05.036_bib7","first-page":"S81","article-title":"A quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012","author":"Tolou-Ghamari","year":"2013","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.talanta.2016.05.036_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1365\/s10337-006-0157-7","article-title":"Isocratic reversed-phase HPLC for simultaneous separation and determination of seven antiepileptic drugs and two of their active metabolites in human plasma","volume":"65","author":"Ma","year":"2007","journal-title":"Chromatographia"},{"key":"10.1016\/j.talanta.2016.05.036_bib9","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00216-010-3673-0","article-title":"Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma","volume":"397","author":"Fortuna","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2016.05.036_bib10","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1039\/C5AY00617A","article-title":"Fluorescence polarization immunoassays for carbamazepine \u2013 comparison of tracers and formats","volume":"7","author":"Oberleitner","year":"2015","journal-title":"Anal. Methods"},{"key":"10.1016\/j.talanta.2016.05.036_bib11","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/epi.12655","article-title":"Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis in Chinese Han patients with epilepsy","volume":"55","author":"He","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.talanta.2016.05.036_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bios.2014.03.047","article-title":"Detection of the antiepileptic drug phenytoin using a single free-standing piezoresistive microcantilever for therapeutic drug monitoring","volume":"59","author":"Huang","year":"2014","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.talanta.2016.05.036_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.phrs.2004.09.008","article-title":"A simple method to monitor plasma concentrations of oxcarbazepine, carbamazepine, their main metabolites and lamotrigine in epileptic patients","volume":"51","author":"Franceschi","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.talanta.2016.05.036_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2013.02.026","volume":"925","author":"Serralheiro","year":"2013","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2016.05.036_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/FTD.0b013e3181c324c8","article-title":"A novel HPLC method for quantification of 10 antiepileptic drugs or metabolites in serum\/plasma using a monolithic column","volume":"32","author":"Heideloff C","year":"2010","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.talanta.2016.05.036_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jssc.200700253","article-title":"Simultaneous determination of antiepileptic drugs and their two active metabolites by HPLC","volume":"31","author":"Budakova","year":"2008","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.talanta.2016.05.036_bib17","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jpba.2008.03.020","article-title":"Quantification of carbamazepine, carbamazepine-10,11-epoxide, phenytoin and phenobarbital in plasma samples by stir bar-sorptive extraction and liquid chromatography","volume":"48","author":"Queiroz","year":"2008","journal-title":"J. Pharm. Biomed."},{"key":"10.1016\/j.talanta.2016.05.036_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/bmc.753","article-title":"Simultaneous determination of lamotrigine, zonisamide, and carbamazepine in human plasma by high-performance liquid chromatography","volume":"21","author":"Greiner-Sosanko","year":"2007","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2016.05.036_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jchromb.2014.09.010","article-title":"Liquid chromatographic assay based on microextraction by packed sorbent for therapeutic drug monitoring of carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin and the active metabolites carbamazepine-10,11-epoxide and licarbazepine","volume":"971","author":"Ferreira","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2016.05.036_bib20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/FTD.0b013e3181678ecb","article-title":"High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry","volume":"30","author":"Subramanian","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.talanta.2016.05.036_bib21","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/bmc.2726","article-title":"Detection of 22 antiepileptic drugs by ultra-performance liquid chromatography coupled with tandem mass spectrometry applicable to routine therapeutic drug monitoring","volume":"26","author":"Shibata","year":"2012","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2016.05.036_bib22","doi-asserted-by":"crossref","first-page":"77689","DOI":"10.1039\/C5RA14678J","article-title":"Identification of the toxic components in Semen Strychni and their metabolites in rat serum by high performance liquid chromatography coupled with a Q Exactive high-resolution benchtop quadrupole Orbitrap mass spectrometer","volume":"5","author":"Li","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.talanta.2016.05.036_bib23","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1021\/ac500140s","article-title":"Ion coalescence of neutron encoded TMT 10-plex reporter ions","volume":"86","author":"Werner","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2016.05.036_bib24","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.1021\/acs.analchem.5b02254","article-title":"Untargeted metabolomics in doping control: detection of new markers of testosterone misuse by ultrahigh performance liquid chromatography coupled to high-resolution mass spectrometry","volume":"87","author":"Raro","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2016.05.036_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.chroma.2014.07.061","article-title":"Large pesticide multiresidue screening method by liquid chromatography-Orbitrap mass spectrometry in full scan mode applied to fruit and vegetables","volume":"1360","author":"Rajski","year":"2014","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.talanta.2016.05.036_bib26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.electacta.2015.05.139","article-title":"Ultrasensitive electrochemical sensor based on CdTe quantum dots-decorated poly(diallyldimethylammonium chloride)-functionalized graphene nanocomposite modified glassy carbonelectrode for the determination of puerarin in biological samples","volume":"173","author":"Yang","year":"2015","journal-title":"Electrochim. Acta"},{"key":"10.1016\/j.talanta.2016.05.036_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.aca.2015.08.018","article-title":"Orbitrap technology for comprehensive metabolite-based liquid chromatographice high resolution-tandem mass spectrometric urine drug screening e Exemplified for cardiovascular drugs","volume":"891","author":"Helfer","year":"2015","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.talanta.2016.05.036_bib28","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1021\/pr500985w","article-title":"Rapid and deep proteomes by faster sequencing on a benchtop quadrupole ultra-high-field Orbitrap mass spectrometer","volume":"13","author":"Kelstrup","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.talanta.2016.05.036_bib29","doi-asserted-by":"crossref","first-page":"19629","DOI":"10.1039\/C4RA01045K","article-title":"Simultaneous determination of a broad range of cardiovascular drugs in plasma with a simple and efficient extraction\/clean up procedure and chromatography-mass spectrometry analysis","volume":"4","author":"Liu","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.talanta.2016.05.036_bib30","doi-asserted-by":"crossref","first-page":"34342","DOI":"10.1039\/C5RA02489G","article-title":"A simple and automated online SPE-LC-MS\/MS method for simultaneous determination of olanzapine, fluoxetine and norfluoxetine in human plasma and its application in therapeutic drug monitoring","volume":"5","author":"Fan","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.talanta.2016.05.036_bib31","first-page":"21","article-title":"Development of a fully automated on-line solid phase extraction and high-performance liquid chromatography with diode array detection method for the pharmacokinetic evaluation of bavachinin: a study on absolute bioavailability and dose proportionality","volume":"893\u2013894","author":"Liu","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2016.05.036_bib32","first-page":"8","article-title":"Optimization of on-line solid phase extraction and HPLC conditions using response surface methodology for determination of WM-5 in mouse plasma and its application to pharmacokinetic study","volume":"923\u2013924","author":"Liu","year":"2013","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2016.05.036_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2125.2001.00394.x","article-title":"Therapeutic drug monitoring-antiepileptic drugs","volume":"52","author":"Eadie","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.talanta.2016.05.036_bib34","doi-asserted-by":"crossref","first-page":"98269","DOI":"10.1039\/C5RA20233G","article-title":"Quantitative performance of online SPE-LC coupled to Q-Exactive for the analysis of sofosbuvir in human plasma","volume":"5","author":"Qu","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.talanta.2016.05.036_bib35","unstructured":"U.S. Department of Health and Human Serivces, F.D.A. C.D.E.R. Guidance for Industry, Bioanalytical Method Validation, 2013."},{"key":"10.1016\/j.talanta.2016.05.036_bib36","article-title":"Approaches to bioanalysis using automated online solid phase extraction-high performance liquid chromatography","author":"Liu","year":"2013","journal-title":"Nankai Univ."},{"key":"10.1016\/j.talanta.2016.05.036_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.chroma.2015.02.059","article-title":"Determining cyclooxygenase-2 activity in three different test systems utilizing online-solid phase extraction-liquid chromatography-mass spectrometry for parallel quantification of prostaglandin E2, D2 and thromboxane B2","volume":"1391","author":"Willenberg","year":"2015","journal-title":"J. Chromatogr. A"}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914016303538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914016303538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T15:26:59Z","timestamp":1572622019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914016303538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":37,"alternative-id":["S0039914016303538"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2016.05.036","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development, validation and clinical application of an online-SPE-LC-HRMS\/MS for simultaneous quantification of phenobarbital, phenytoin, carbamazepine, and its active metabolite carbamazepine 10,11-epoxide","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2016.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}